Connect and Interact
with Industry, Academia, and Regulatory Experts from Around the World.
DIA’s educational portfolio addresses all of today’s
hottest topics, including biosimilars, PDUFA, rare diseases & orphan
products, medical devices and diagnostics, as well as the new research
and analysis that’s occurring after a product has been approved and
available in the marketplace.
Plan
Now for the Fall!
DIA/FDA
Biosimilars Conference: Guidances, Science, and BsUFA
September 12-13 | Washington, DC
DIA/FDLI
Unwrapping FDA’s 2012 UFA Package: What’s Inside the Statute, What’s
Next?
September 20 | Washington, DC
EDM
and ERS/eCTD: The Content Continuum from Document Authoring through
Submission Delivery
October 8-11 | Baltimore, MD
Register by
September 17 to Save!
Principles
and Practical Approaches to Global Benefit-Risk Management
October 9-10 | Silver Spring, MD
Register by
September 18 to Save!
Global
Labeling 2012: Impact on Risk Management & Other Global and
Regional Initiatives
October 11-12 | Silver Spring, MD
Register by September
20 to Save!
DIA/FDA
Industry PDUFA V Conference
October 18-19 | Arlington, VA
US
Conference on Rare Diseases & Orphan Products: Shaping the Future
Now
October 22-24 | Washington, DC
Register by
October 1 and Save!
DIA/FDA:
Revitalizing R&D Productivity in Drug Development
October 23-24 | Bethesda, MD
DIA’s
Annual Canadian Meeting: Evolutions in Risk Thinking
November 5-7 | Ottawa, ON Canada
Register by
October 19 and Save!
FDA
Information Day: Individual Case Safety Reports (ICSR)
November 29-30 | Silver Spring, MD
Save the Date:
DIA Combination Products Regulatory Workshop: Approval
Pathways for
Drug/Device
Combinations and Companion Diagnostics
November 7-8 | Washington, DC
Data Monitoring Committees: Best Practices and Future
Directions
November 2012 | Washington, DC
|
No comments:
Post a Comment